Viewing Study NCT00132002

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:48 AM

Ignite Modification Date: 2025-12-26 @ 2:35 AM

Study NCT ID: NCT00132002

Status: TERMINATED

Last Update Posted: 2015-03-19

First Post: 2005-08-16

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer

Sponsor: National Cancer Institute (NCI)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module